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Abstract 
Approaches to the polyene natural product xanthomonadin, an octaenyl electron-deficient 
bacterial photoprotective agent, and its debromo analogue, were developed. These 
involvedthe iterative cross-coupling of multiple C2-fragments, using a vinylboronate ester as 
a formal vinyl dianion equivalent. Vinyl iodide starting materialsundergo Heck-Mizoroki cross-
coupling at ambient temperatures, allowing further iododeboronation to derive the next vinyl 
iodide. This works in a highly effective manner to access systems of up to pentaene chain 
length. However, final assembly of polyenylboronates with such polyenyl iodides through their 
Suzuki-Miyaura cross-coupling was less successful, even at lower temperatures, reflecting 
the extreme sensitivity of such octaenylxanthomonadin analogues. Despite this, the mild 
cross-coupling conditions could be effectively applied to the assembly of a range of useful 
polyenyl building blocks, as well as a truncated pentaenyl-debromoxanthomonadin analogue. 
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1 Introduction 
Polyenes represent an important class of natural product, showing diverse biological activity 
as antibiotics, anti-cancer agents, anti-oxidants and photo-protective agents. Together with 
their biological importance, their stereochemical and chemical properties make the synthesis 
of polyenes, both natural and unnatural, a particular synthetic challenge from both strategic 
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and methodology standpoints.1,2 Established methodologies for the synthesis of such 
compounds have historically relied upon bespoke syntheses using Wittig-type reactions and 
more recently cross-coupling reactions to link individually prepared fragments. Both 
approaches have associated issues, particularly with regard to atom economy in the case of 
Wittig reactions, toxicity in the case of the most popular Stille coupling, as well as more general 
concerns regarding the stability of the products under the reactions conditions, the general 
applicability of reactions, and the ability to achieve complete stereocontrol.3 For instance, we 
demonstrated that the Heck-Mizoroki cross-coupling of vinyl dianion equivalents, 
vinylboronate esters, could be used in conjunction with a combination of iodo-deboronation 
(IDB) and Suzuki-Miyaura cross-couplings, i.e. an iterative cross-coupling (ICC) approach to 
polyenes,4 that was then applied towards the synthesis of natural product polyenes such as 
phthoxazolin A and viridenomycin.5 In recent years, this iterative cross-coupling has been 
further exemplified by the use of MIDA boronates, which have seen increasing use in the 
synthesis of such compounds. Burke and co-workers also successfully applied MIDA boronate 
methodology for the synthesis of amphotericin B and a range of synthetic analogues.6,7 The 
two approaches have significant advantages over the previously mentioned alternatives: in 
particular, the need to design a new synthesis for each target compound is eliminated, and 
the issue of stereoselectivity is in principle reduced considerably through the inherent control 
that is available through the types of cross-coupling protocols employed. 
 
 
 
Scheme 1 State-of-the-art in polyene synthesis and selected synthetic targets 
 
Despite these advancesour studies towards the stereoselective synthesis of several electron-
deficient polyenes, variants of the photo-protective bacterial pigment xanthomonadin,8 
showed such systems to be particularly susceptible to E/Z isomerisation. Whilst our 
development of mild reaction conditions to perform our key Heck-Mizoroki (HM) reaction at 50 
°C made the synthesis of many such compounds feasible,5c we subsequently found that for 
some substrates, even this temperature did not always achieve the high stereoselectivity 
intended. In particular, we have found that the xanthomonadin system represents a particularly 
significant synthetic challenge,9 even more so due to the inherent instability of the substituted 
polyenes involved, both as intermediates and final products. We have recently demonstrated 
that shorter chain analogues of the xanthomonadin pigments are accessible by our previously 
reported methodology, and shown one of these to be photoprotective in E. coli.9b These 
studies also suggested that the 7-debromo analogue of xanthomonadin, itself a putative 
natural product, retains this photoprotective activity. Herein we discuss the further 
development of our methodology towards the synthesis of less stable, longer chain 
xanthomonadin polyene natural product analogues and the key issues associated with this 
significant synthetic challenge. 
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Our original retrosynthetic strategy for methyl xanthomonadin and debrominated methyl 
xanthomonadin 9a and 9b involved utilising our ICC methodology.4,5,9 The length of the 
polyene chain made various disconnections viable, though in all cases a final SM coupling 
was employed as outlined in Scheme 2. These disconnections led to known iodide 110 and to 
either styrylboronate 10 or styryliodide 15 depending upon the point of disconnection (Scheme 
2). Whilst both 10 and 15 are accessible from our previous work towards the synthesis of 
shorter chain xanthomonadin analogues,9 disconnection a) initially appeared more promising 
due to the previously documented poor reactivity of iodide 15a in the HM chemistry necessary 
to begin its extension to a polyene chain.9a 
 
 
Scheme 2. Representative retrosyntheses of xanthomonadin and debromoxanthomonadin  
 
2 Results and Discussion 
 
Initial attempts to prepare methyl xanthomonadin 9a, therefore, focussed upon disconnection 
a), applying our vinylboronate ester-mediated HM/IDB methodology to the synthesis of key 
heptaenyl iodide building block 11. This approach proved successful up to accessing pentaene 
16 (Scheme 3); however, from this point, polyene chain extension became increasingly 
challenging due to the poor stability of the polyenyl intermediates. Attempting to solve this by 
telescoping reaction steps, in order to avoid contact with silica and minimise issues with 
handling, proved only partially successful and it remained clear from NMR analysis of 1111 that 
both isomerisation and decomposition was readily occurring. 
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Scheme 3. Attempted synthesis of xanthomonadin building block, heptaenyliodide 11, using 
ICC methodology 
 
These attempts highlighted the need for a revised approach towards the synthesis of 
xanthomonadin and its analogues, necessarily employing milder conditions and ideally 
minimising the use of such long chain, electron-deficient polyenyl iodide intermediates, i.e. 
such as 11. As discussed above, the lack of reactivity of the brominated styrenyl iodide 15a to 
HM coupling necessitated the synthesis of heptaene 11 for the synthesis of xanthomonadin 
9a itself; however, we have recently demonstrated that debrominated xanthomonadin 
analogues demonstrate photo-protective effects.9 We therefore elected to focus upon 
developing a route to debrominated methyl xanthomonadin 9b, permitting the use of  a wider 
range of disconnection approaches, as outlined in Scheme 2. 
 
To this end, debromo-styrylboronate 10b was synthesised as described previously,9a and 
subjected to IDB and HM steps (Scheme 4). The resulting dienyl boronate 17 was then 
successfully taken through a further two HM/IDB cycles, to yield aryl tetraenyl boronate 21. 
Due to concerns regarding stability, the reaction steps were initially telescoped without 
purification of intermediates, with the boronate products being characterised after each cycle 
by only HRMS to ensure the coupling reactions were proceeding as expected. This strategy 
proved successful, despite the final estimated yield being relatively low, i.e. with an overall 
yield of 5% over 6 steps. Repeating the sequence with purification of the intermediate 
boronates was then attempted, leading to a dramatic increase in the overall yield to 9%, or 
67% on average per step, though purification of the polyenyl iodides was again avoided due 
to concerns over their stability. Some reduction in yield was however observed as the length 
of the polyene chain increased, with this trend being particularly obvious in the HM steps (see 
Scheme 4). This likely reflects a lack of stability of the intermediate iodides to the HM reaction 
conditions; indeed, whilst the polyenyl boronates appeared more stable than their ester 
functionalised counterparts (i.e. boronates 12 vs. 13), the iodides appeared less stable even 
at this moderate polyene length. For instance, trienyl iodide 20 proved to be unstable even at 
room temperature in the absence of light, gradually changing from a bright yellow compound 
to a brownish material within two hours.11 
 
 
Conditions: a) Pd(OAc)2 (5 mol%), P(o-tol)3 (10 mol%), AgOAc (1.1 equiv.), MeCN, 50 ° C; 
b) i) NaOMe (1.2 equiv.), THF, MeOH, -78 ° C; ii) ICl (1.02 equiv.), DCM, to rt. 
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Scheme 4. Construction of aryl tetraenyl boronate 21 
 
The observation that both sets of polyenyl iodides were unstable led us to consider whether 
our key HM step could be performed at an even lower temperature. Lower temperature SM 
coupling conditions have been reported previously,5,9,12 and this led us to consider whether 
the same could be achieved for the key HM step. In order to assess how low the temperature 
would need to be to allow the reaction to proceed while ensuring greater starting material 
stability under the reaction conditions, tetraenyl iodide 22 was prepared and its thermal 
stability assessed in degassed d3-MeCN. Samples were thus prepared and stored (in the 
absence of light) at different temperatures, leading to the results shown in Table 1. 
 
Table 1. Effect of heat on tetraenyl iodide 22 
 
 
Entry Temperature/ oC Colour change over 2 hours 
Remaining product after 2 
hours /%a 
1 rt None 97 
2 30 None 96 
3 40 None 90 
4 50 None 89 
5 60 Yellow-pink-dark brown 84
b 
aMeasured by comparison of 1H NMR spectrum integrals between starting material and major impurity 
(multiplet at 9.65 ppm) after 2 hours  bMultiple new peaks observed, suggesting multiple decomposition 
products. 
 
It can be seen from Table 1 that even in the absence of catalysts and other reagents, iodide 
22 showed reduced stability at both 40 and 50 °C. However, it also appeared that if the reaction 
temperature could be reduced to room temperature or even 30 °C, improved results might be 
expected. We therefore investigated the effect of the reaction temperature on the HM reaction 
of iodoacrylate 1, this substrate being chosen as a model due to its ease of preparation and 
well understood reactivity under such conditions.5c Table 2 shows the effect of varying both 
the temperature and catalyst loading for the HM cross-coupling of iodide 1 with vinylboronate 
3.  
 
Table 2. Temperature screen for the HM coupling of iodide 1 and boronate 3, showing HM vs 
competing SM ratios. 
	
 
Entry Catalyst loading/ mol% Temperature / oC Conversion after 24 h/ % 
HM (23): 
SM (24)a 
1 5 50 100 97:3 
2 5 40 100 87:13 
3 10 40 100 80:20 
4 5 30 100 87:13 
5 10 30 100 85:15 
6 5 rt 100 72:28 
7 10 rt 100 68:32 
aDetermined by 1H NMR analysis of the crude reaction mixture. 
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As can be seen from Table 2, all temperatures and catalyst loadings led to full conversion of 
the starting materials; however, the combined effect of both temperature and catalyst loading 
on the HM/SM product ratio was surprising. Whilst the formation of both HM and SM products 
is always possible in such reactions, our previously developed reaction conditions had 
afforded high selectivity for HM products.5c-d With selectivity becoming particularly problematic 
at room temperature, we felt that the results at 30 °C represented a good balance between 
reaction success and the stability of the longer chain polyenyl iodides. Hence, application of 
these particular conditions to the synthesis of tetraenyl iodide 22 at a reduced temperature 
was carried out. Despite issues with purification of the final product, this approach was indeed 
successful, resulting a 50% overall yield of boronate 27 , i.e. reflecting an 87% average yield 
per step (see Scheme 5). In all cases, it was noted that the competing SM product was formed 
under the HM reaction conditions, however, this was compensated for by reduced 
decomposition of the reacting iodides at the lower reaction temperature employed. 
 
 
Conditions: a) Pd(OAc)2 (5 mol%), P(o-tol)3 (10 mol%), AgOAc (1.1 equiv.), MeCN, 30 ° C; 
b) i) NaOMe (1.2 equiv.), THF, MeOH, -78 ° C; ii) ICl (1.02 equiv.), DCM, to rt. 
Scheme 5. Reduced temperature ICC methodology to access tetraenyl iodide 22 
Having investigated and reduced the HM coupling reaction temperature, we then turned to the 
application of these conditions on the previously discussed aryl system starting with 
styrylboronate 10b (Scheme 6). These improved reaction conditions proved more successful 
than previous attempts, with intermediates proving to be reactive even at the lower 
temperatures, demonstrated by tetraenylboronate 21 being prepared efficiently (Scheme 6) 
with the overall yield of boronate 21 doubling to 18% over 6 steps i.e. reflecting a 75% average 
yield per step. This increase in yield appears to be due entirely to the reduced decomposition 
during the HM step of the cycle through use of the lower temperature conditions. 
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Conditions: a) Pd(OAc)2 (5 mol%), P(o-tol)3 (10 mol%), AgOAc (1.1 equiv.), MeCN, 30 ° C; 
b) i) NaOMe (1.2 equiv.), THF, MeOH, -78 ° C; ii) ICl (1.02 equiv.), DCM, to rt. 
Scheme 6. Synthesis of aryl tetraenylboronate 21 with 30 °C HM reactions 
Despite this improvement, we remained curious as to whether this reaction could be made 
more efficient. In particular, we hoped that variation of the ligand, coupled with the reduced 
temperatures already employed, might allow an increase in reaction selectivity and thus 
overall yield, providing more material for SM studies. A small ligand screen was therefore 
performed and the results are shown in Table 3. 
 
Table 3. Ligand screen for the HM coupling of iodoacrylate 1 and vinylboronate 3, showing 
HM versus competing SM ratios.a 
	  
Entry Ligand Conversion after 3 h/% HM: SM ratio
b 
1 No ligand 100 80:20 
2 Tri(o-tolyl)phosphine 100 68:32 
3 Triphenylphosphine 0 - 
4 Tris(o-methoxyphenyl)phosphine 100 89:11 
5 Tris(4-trifluoromethylphenyl)phosphine 0 - 
6 Trifurylphosphine 100c 89:11 
aReaction undertaken using 10 mol% catalyst and 2 equivalents ligand relative to catalyst. bRatios 
determined by 1H NMR spectroscopy on the crude reaction. cReaction complete after 1.5 hours 
The results in Table 3 show that whilst tri(o-tolyl)phosphine is highly effective50 °C, at room 
temperature the complete absence of  ligand is in fact preferable in terms of selectivity (Entries 
1 and 2). In addition, while triphenylphosphine and tris(4-trifluoromethyl)phosphine (Entries 3 
and 5) were found to give no reaction, the more electron rich tris(o-methoxyphenyl)phosphine 
and tri(2-furyl)phosphine both gave full conversion with dramatically improved HM/SM 
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selectivity (see Entries 4 and 6) with tri(2-furyl)phosphine in particular also providing rapid 
reaction with the catalyst loading employed. 
 
With the ideal ligand identified, we undertook to reduce the catalyst loading, as shown in Table 
4. 
 
Table 4. Catalyst loading screen for the HM coupling of iodoacrylate 1 and vinylboronate 3, 
showing HM vs competing SM ratiosa 
	  
Entry Catalyst loading/ mol% 
Conversion after 
3 h/% 
HM: SM 
ratio after 3 
h 
Conversion 
after 25 h/% 
HM: SM 
ratio after 
25 hb 
1 10 100 89:11 100 87:13 
2 7.5 100 90:10 100 90:10 
3 5 100 91:9 100 89:11 
4 2.5 100 89:11 100 88:12 
5 1 100 88:12 100 89:11 
6 0.5 <1 - 31 77:23 
         aReaction undertaken using 2 equivalents ligand relative to catalyst. bRatios determined by 1H NMR 
spectroscopy on the crude reaction. 
 
As can be seen from Table 4, optimisation of the catalyst loading also proved highly 
successful, with 1 mol% palladium (Entry 5) being viable without loss of activity or selectivity 
for the HM reaction. Interestingly, a further reduction to 0.5 mol% led to not only to a dramatic 
reduction in conversion but also resulted in a significant erosion of chemoselectivity (Entry 6). 
Indeed, these observations are intriguing from a mechanistic perspective, because it is far 
from obvious that reducing the reaction temperature or decreasing the catalyst loading should 
lead to an erosion in HM selectivity. We have previously considered selectivity between the 
two possible pathways, as it represents a key aspect of our HM/IDB methodology. In fact, the 
high HM selectivity of the 50 °C conditions were somewhat unexpected given the results that 
preceded them,involving the use of a trialkylamine base in an apolar solvent;4a,d,13 here it was 
generally found that the use of inorganic bases such as silver(I) carbonate favoured the SM 
pathway.13,14 These amine base conditions were extended to a variety of substrates, but were 
ultimately too aggressive for the HM reactions of electron-deficient alkenes.14 At this point the 
use of tri(o-tolyl)phosphine and silver(I) acetate in acetonitrile was developed through a 
combination of mechanistic investigation and screening of conditions.8a The lack of SM 
reaction in the presence of Ag(I) acetate (as compared to silver(I) carbonate) presumably 
reflects either the acetate anion’s poor capacity to complex both Pd and the incoming boronate 
in the transition state of the transmetallation step, or its inability to form hydroxide from 
adventitious water due to its low basicity. Further, our work on HM reactions of other systems4 
suggests that the introduction of a species capable of generating a significant degree of 
boronate "ate"-complex formation is likely to reduce the rate of HM reaction. The full role of 
silver(I) acetate in these conditions remains unclear, however, with both the cation and anion 
being required to obtain high catalytic activity, we consider it likely that acetate forms an 
activating additive for the catalyst as well as a weak base catalyst turnover, whilst the silver 
cation itself plays a role in removing halide from the reaction, perhaps facilitating catalyst 
activation or turnover.  However, these considerations do not explain why SM coupling should 
increasingly compete as the temperature is lowered. The fact that tri(2-furyl)phosphine and 
tris(2-methoxyphenyl)phosphine form the two most selective catalytic systems is somewhat 
surprising given that the former represents a smaller, less basic phosphine than tri(o-
tolyl)phosphine (Tolman cone angle 133° vs 194°, respectively15,16), whereas the latter is 
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somewhat more electron rich and similarly bulky.17 One possible explanation, accounting for 
both observations, comes from the resting state of the tri(o-tolyl)phosphine system, which is 
known18 to form the ortho-palladated Herrmann’s catalyst. It seems plausible that without 
sufficient thermal activation, the reductive step required to form the catalytically active 
species19 could become sluggish, leading to a significant change in reactivity; indeed, the 
activity of this catalyst in related systems has been reported as requiring temperatures of 80 
°C.18 However, the lack of observed reactivity in the case of triphenylphosphine and tris(4-
trifluoromethylphenyl)phosphine also demonstrates that the reaction can in fact be highly 
sensitive to changes in electronics, raising the question of why the electronically different tri(2-
furyl)phosphine and tris(2-methoxyphenyl)phosphine should be similarly effective. This may 
relate to complex pre-equilibria behaviour, balancing the advantages of electron-rich catalysts 
against a need for ligand dissociation. Indeed, such effects are well documented for tri(2-
furyl)phosphine-based systems in particular,20 and further work would clearly be required to 
achieve a full understanding of complex mechanistic behaviour controlling selectivity in this 
system. 
 
Having established room temperature conditions for the HM coupling, the synthesis of 
tetraenyl iodide 22 was performed at room temperature with a reduced catalyst loading (1 
mol% vs. 5% as employed previously) as shown in Scheme 7. As with the reduction in 
temperature to 30 °C, cleaner reactions were observed, as well as good crude mass recovery. 
The yields themselves were either comparable, or better than, those obtained at 30 °C, despite 
the use of 80% less catalyst. Indeed, exceptionally high yields were obtained at room 
temperature for the first two HM couplings, which represents a marked improvement to the 
HM coupling conditions with the lower ligand loading at room temperature causing less of a 
build-up of phosphine-derived species (likely phosphine oxides) in the telescoped material, as 
well as a reduction in side-product formation. However, the bottleneck in this synthesis 
remained the final IDB step, where a large amount of material was lost upon purification. 
Despite this, these conditions remain a considerable improvement over those we have 
employed in the past, i.e. achieved through the reduction in both temperature and catalyst 
loading, leading to a significant increase in overall yield.  
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Scheme 7. Improvements in yield after optimisation of the HM methodology for the synthesis 
of tetraenyliodide 22 
 
With highly efficient access to the required tetraenyl intermediates now established, we 
attempted to access debrominated methyl xanthomonadin 9b, utilising the conditions 
employed in our published synthesis9 of truncated analogue 4 for the final SM coupling. 
However, whilst a number of attempts were made to react tetraenylboronate 21 with 
tetraenyliodide 22, and analysis of the crude reaction mixture by 1H NMR spectroscopy and 
mass spectrometry suggested the presence of the desired product 9b, its isolation proved 
elusive on all occasions. This was attributed largely to rapid decomposition on silica gel, as 
demonstrated by 2D TLC analysis which clearly indicated high instability. Direct precipitation 
from the reaction mixture, as described in the original isolation of methyl xanthomonadin 9a,8 
was also attempted. This procedure led to the isolation of a red solid which was mainly 
triphenylphosphine oxide, however, it also contained a highly conjugated polyene (2% yield 
according 1H NMR spectroscopy) which was again consistent with debrominated methyl 
xanthomonadin 9b by high resolution MS (Equation 4). However, the poor yield and our 
inability to separate the product from the rest of the reaction by-products meant that this 
approach remained an insufficient solution to the final assembly step of the synthesis, though 
not through insufficient cross-coupling reactivity, rather through a product stability issue. 
 
 
 
Equation 1. Attempted Suzuki coupling of tetraenes 21 and 22 
Given this instability of systems of type 9b, we turned to our truncated bioactive analogue 4 
as a better model by which to examine the room temperature conditions for the final SM 
coupling. Indeed, this proved to be the case, and after some experimentation employing 
Pd(OAc)2 and 3 equivalents of PPh3 to generate a coordinatively unsaturated Pd species in 
situ, combined with a non-nucleophilic silver-derived base, allowed the SM to be performed at 
room temperature, with a dramatic improvement in yield, i.e. from 34% to 81% (Equation 5). 
Therefore, if one removes the issues associated with longer chain polyene stability (i.e. 
dropping the polyene chain-length from an octaene to a pentaene, it is possible to show that 
these types of cross-couplings are viable and of genuine utility. 
 
 
 
Equation 2. Suzuki coupling to form truncated analogue 4 
 
3 Conclusion 
In conclusion, improved low temperature, low catalyst-loading cross-coupling conditions have 
been developed to allow the synthesis of particularly unstable unsubstituted polyenic 
xanthomonadin analogues under mild reaction conditions, highlighting in the process the 
mechanistic complexities that underpin Suzuki-Miyaura vs. Heck-Mizoroki reaction selectivity 
in such systems. Further, whilst such polyenic molecules may be synthesised using this 
methodology, the purification of such systems remains a considerable challenge especially for 
the long-chain analogues. While we could demonstrate the formation of longer-chain, octaene 
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systems, the improved conditions reported in this paper were more readily exemplified on 
shorter chain, pentaene systems, i.e. through the synthesis of truncated analogue 4 which 
showed a considerable increase in yield (Table 5) as the temperature was lowered. This 
clearly demonstrates the benefit of applying these low temperature conditions in the synthesis 
of polyenes that do not present formidable challenges in terms of purification. Indeed, such 
conditions are likely to be of considerable use for the synthesis of other polyene-containing 
structures which do not present the major stability challenge of the xanthomonadins, permitting 
the controlled synthesis of a range of stereoisomers at low temperature and catalyst loading. 
 
Table 5. Effect of cross-coupling conditions on the yield of truncated xanthomonadin analogue 
4 
 
Temperature for HM Temperature for SM Overall yield (12 steps)/ % 
Average yield per 
step/ % 
50 °C 40 °C 2 72 
30 °C 40 °C 5 78 
rt rt 12 84 
 
Concerning the issue of the stability of the longer chain polyenic systems, it may be the case 
that solid supported catalysts could be utilised to overcome product stability and isolation, i.e. 
with the ideal situation perhaps being the removal of all unwanted by-products, e.g. catalysts, 
ligands by filtration. This will still leave the challenge of separation of any residual starting 
materials and isomeric polyenic products, but could be the solution to managing the silica gel, 
air and light sensitive compounds. Overall of course, one has to marvel at the power of Nature 
when it comes to the synthesis of complex and unstable molecules whose function relates to 
their high reactivity. There is strong evidence that the xanthomonadin pigments are lipid bound 
(perhaps to impart some stability),8,21 and this suggests that the development of new synthetic 
tools alone may not always be sufficient to match this prowess and ability to microencapsulate 
products enabling them to be stored long enough to act as effective photoprotective agents.  
 
 
 
4 Experimental 
 
4.1 General experimental 
All reactions were carried out in oven-dried glassware with magnetic stirring unless otherwise 
stated. All chemicals were purchased from commercial suppliers and used without further 
purification. For synthesis of substituted polyene intermediates and final products,  
~ 3 ppm of BHT radical inhibitor was added to all reaction, work-up and purification solvents. 
Where petroleum ether is stated, this refers to petroleum ether bp  
40-60 °C. Anhydrous acetonitrile was obtained by distillation of HPLC grade acetonitrile over 
calcium hydride. Anhydrous THF was obtained by distillation of HPLC grade THF over sodium 
metal, with a benzophenone indicator. Solvents were degassed, unless stated otherwise, by 
sparging with argon for 20 minutes. For all palladium cross-coupling reactions, cross-shaped 
stirrer bars were used for the most efficient stirring. Monitoring of reactions was achieved using 
TLC and/or 1H NMR. TLC was performed using silica plates. The silica plates were polyester-
backed silica TLC plates with 0.2 mm silica gel and fluorescent indicator. Spots were 
visualised using an ultraviolet (UV) lamp and KMnO4 dip, visualising in both long wave and 
short-wave UV. NMR experiments were carried out on either a Bruker Avance-400 or a Varian 
VNMRS-700 spectrometer in deuterated chloroform (CDCl3-d), deuterated methanol (MeOD-
d4), or deuterated dimethyl sulfoxide (DMSO-d6). Chemical shifts are reported in ppm relative 
to tetramethylsilane (TMS) reference. Experiments undertaken included 1H, 11B, 19F, 13C, 
COSY, PSYCHE, HSQC and HMBC NMR. Celite/silica filtration used Celite® S and technical 
grade silica gel: pore size 60 Å, 230-400 mesh particle size, 40-63 μm particle size. The term 
‘evaporated’ refers to the removal of solvent in vacuo. Silica gel chromatography used 
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technical grade silica gel: pore size 60 Å, 230-400 mesh particle size, 40-63 μm particle size. 
Where 0 °C is referred to as the temperature for column chromatography, all eluents were 
pre-cooled on ice and added to the column in small enough amounts to be confident that a 
low temperature was maintained throughout the column. A few drops of eluent containing ~3 
ppm BHT radical inhibitor was also added to the bottom of each vial intended for collecting 
fractions. Electrospray ionisation (ESI) mass spectroscopy was undertaken using a LTQ FT 
(ThermoFinnigan) high resolution, accurate mass LC ES MS/MS or a Thermo Scientific LTQ 
Orbitrap XL. Samples were made up as 1 mg per mL solutions in acetonitrile. GC/MS EI was 
undertaken using a Waters GCT Premier. Atmospheric solids analysis probe (ASAP) mass 
spectroscopy was undertaken using LCT Premier XE (Waters) high resolution, accurate mass 
ultra-performance liquid chromatography (UPLC) ASAP or a Thermo Scientific LTQ Orbitrap 
XL. Samples were either made up as 1 mg per mL solutions in acetonitrile or run as solids. 
Infra-red (IR) spectroscopy was undertaken using a Perkin Elmer-1600 FTIR, using both liquid 
and solid samples. Melting point measurements were undertaken using a Gallenkamp melting 
point apparatus. UV-Vis measurements were carried out on a Varian Cary 100 Bio UV-Visible 
Spectrophotometer. Fluorescence measurements were carried out on a Jasco FP-6200 
Spectrofluorometer. Both UV-Vis and fluorescence measurements were carried out using 
quartz cuvettes, with samples dissolved in either spectrophotometric grade diethyl ether, or 
spectrophotometric grade chloroform. 
 
4.2 Specific experimental procedures 
(2E,4E)-5-(4,4,6-Trimethyl-[1,3,2-dioxaborinan-2-yl]-penta-2,4-dienoic acid methyl ester 23 
Method 1: To a dry Schlenk flask was added Pd(OAc)2 (36 mg, 0.16 mmol), P(o-tol)3 
(0.10 g, 0.33 mmol) and AgOAc (0.601 g, 3.60 mmol). The flask was purged with argon, and 
dry, degassed MeCN (10 mL) was added. 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.655 
mL, 3.80 mmol) was then added, followed by methyl (2E)-3-iodoprop-2-enoate (0.704 g, 3.32 
mmol). The vessel was purged further with argon, and the reaction mixture was then heated 
to 50 °C with vigorous stirring for 2 days. The mixture was allowed to cool, then diluted with 
Et2O (280 mL) and passed through a short Celite/silica plug. The organic extracts were 
washed with 5% HCl (40 mL), H2O (80 mL) and brine (80 mL), dried over MgSO4, filtered and 
evaporated to yield 0.98 g of crude product as an orange oil. The crude product was purified 
by silica gel chromatography, eluent 10% EtOAc in hexane elution. Pure fractions were 
evaporated to yield (2E,4E)-5-(4,4,6-trimethyl-[1,3,2-dioxaborinan-2-yl]-penta-2,4-dienoic acid 
methyl ester as a yellow oil (0.404 g, 51%). 1H NMR (400 MHz, CDCl3): δ 1.35-1.24 (9H, m), 
1.5-1.47 (1H, m), 1.81 (1H, dd, J=14.0, 2.9 Hz), 3.75 (3H, s), 4.24 (1H, dqd, J=12.3, 6.2, 2.9 
Hz), 5.99-5.86 (2H, m), 6.97 (1H, ddd, J=17.3, 11.0, 0.7 Hz), 7.33-7.21 (1H, m); 11B NMR (128 
MHz, CDCl3): δ 25.52; 13C NMR (101 MHz, CDCl3): δ 23.58, 28.62, 31.65, 46.41, 52.12, 65.52, 
71.67, 123.17, 143.89, 146.54, 167.93; IR (nmax, cm-1) 2974.3 (w) 1719.5 (s) inter alia; LCMS 
(ESI+) 239.2 ; HRMS (ESI+) calculated [C12H19BO4+H]+ 238.1470, found 238.1491.  
Method 2: To a dry flask was added methyl (2E)-3-iodoprop-2-enoate (2.82 g, 13.3 
mmol), Pd(OAc)2 (0.150 g, 0.67 mmol), P(o-tol)3 (0.408 g, 1.34 mmol) and AgOAc (2.41 g, 
14.4 mmol).  The flask was purged with argon, and dry, degassed MeCN (80 mL) was added. 
4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (2.6 mL, 15 mmol) was then added, the vessel 
was purged further with argon, and the reaction mixture was then heated to 50 °C with 
vigorous stirring for 23 hours. The mixture was allowed to cool, then diluted with Et2O (200 
mL) and passed through a short Celite/silica plug. The organic extracts were washed with 
NH4Cl (200 mL), H2O (200 mL) and brine (200 mL), dried over MgSO4, filtered and evaporated 
to give crude product as a yellow oil (2.65g, 83%). The compound was taken on to the next 
stage without any further purification or characterisation. 
Method 3: To a dry flask was added methyl (2E)- 3-iodoprop-2-enoate (2.82 g, 13.3 
mmol), Pd(OAc)2 (0.15 g, 0.67 mmol), P(o-tol)3 (0.408 g, 1.34 mmol) and AgOAc (2.41 g, 14.4 
mmol).  The flask was purged with argon, and dry, degassed MeCN (72 mL) was added. 4,4,6-
Trimethyl-2-vinyl-1,3,2-dioxaborinane (2.6 mL, 15 mmol) was then added, the vessel was 
purged further with argon, and the reaction mixture was then heated to 30 °C with vigorous 
stirring for 19 hours. The mixture was allowed to cool, then diluted with Et2O (200 mL) and 
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passed through a short Celite/silica plug. The solvent was evaporated to give crude product 
as a yellow oil (2.84g, 89%). The compound was taken on to the next stage without any further 
purification or characterisation. 
Method 4: To a dry flask was added methyl (2E)-3-iodoprop-2-enoate (1.0 g, 4.7 
mmol), Pd(OAc)2 (0.011 g, 0.047 mmol), tri(2-furyl)phosphine (0.022 g, 0.094 mmol) and 
AgOAc (0.851 g, 5.11 mmol). The flask was purged with argon, and dry, degassed MeCN (28 
mL) was added. 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.93 mL, 5.4 mmol) was then 
added, the vessel was purged further with argon, and the reaction mixture was stirred 
vigorously at room temperature for 3 days. The mixture was diluted with Et2O (71 mL) and 
passed through a short Celite/silica plug. The solvent was evaporated to give crude product 
as a pale yellow oil (1.18 g, 99%). The compound was taken on to the next stage without any 
further purification or characterisation. 
 
Methyl (2E,4E)-5-iodopenta-2,4-dienoate 2 
Method 1: NaOMe (4.2 mL, 2.1 mmol, 0.50 M solution in MeOH) was added dropwise 
to a solution of (2E,4E)-5-(4,4,6-trimethyl-[1,3,2-dioxaborinan-2-yl]-penta-2,4-dienoic acid 
methyl ester (0.404 g, 1.70 mmol) in THF (6.0 mL) cooled to -78 °C for 1 hour 50 minutes. 
Iodine monochloride (2.0 mL, 2.0 mmol, of a 1.0 M solution in DCM) was added dropwise and 
the reaction stirred for a further 2 h. The reaction mixture was allowed to warm to room 
temperature whilst stirring. The mixture was diluted with Et2O (60 mL) and washed with 5% 
Na2S2O3 (2 x 20 mL), H2O (20 mL) and brine (20 mL). The organic extracts were dried over 
MgSO4, filtered and evaporated to yield a pale orange solid. The crude material was purified 
by silica gel chromatography, eluent 5% EtOAc in petroleum ether at 0 °C. Pure fractions were 
evaporated to yield methyl (2E,4E)-5-iodopenta-2,4-dienoate as a white solid (0.337 g, 83%). 
1H NMR (400 MHz, CDCl3): δ 3.75 (3H, s), 5.84-5.98 (1H, m), 6.89-6.98 (1H, m), 7.12-7.22 
(2H, m); 13C NMR (101 MHz, CDCl3): δ 51.6, 121.0, 125.1, 136.4, 142.9, 167.1. The compound 
was taken on to the next stage without any further characterisation.  
Method 2: NaOMe (28 mL, 14 mmol, 0.50 M solution in MeOH)  was added dropwise 
to a solution of (2E,4E)-5-(4,4,6-trimethyl-[1,3,2-dioxaborinan-2-yl]-penta-2,4-dienoic acid 
methyl ester (2.84 g, 11.9 mmol) in THF (44 mL) cooled to -78 °C under argon in the absence 
of light. The mixture was stirred at this temperature for 1 hour 5 minutes and iodine 
monochloride (12 mL, 12 mmol, of a 1.0 M solution in DCM) was added dropwise. The mixture 
was stirred at -78 °C for 2 hours, then allowed to warm to room temperature whilst stirring. 
The mixture was diluted with Et2O (356 mL) and washed with 5% Na2S2O3 (2 x 142 mL), water 
(142 mL) and brine (142 mL). The organic extracts were dried over MgSO4, filtered and 
evaporated to 3.2 g of a brown oil containing desired product (2.14 g, 76%). The compound 
was taken on to the next stage without any further purification or characterisation. 
 
Methyl (2E,4E,6E)-7-(4,4,6-trimethyl-1,3,2-dioxaborinane-2-yl)hepta-2,4,6-trienoate 25 
Method 1: To a dry Schlenk flask was added Pd(OAc)2 (16 mg, 0.071 mmol), P(o-tol)3 
(43 mg, 0.14 mmol) and AgOAc (0.284 g, 1.7 mmol), followed by a solution of (2E,4E)-5-
iodopenta-2,4-dienoate (0.337 g, 1.42 mmol) in dry, degassed MeCN (4.5 mL). 4,4,6-
Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.24 mL, 1.4 mmol) was then added and the reaction 
mixture was then heated to 50 °C with vigorous stirring for 2 days. The mixture was allowed 
to cool, then diluted with Et2O (80 mL) and passed through a short Celite/silica plug. The 
organic extracts were washed with H2O (40 mL) and brine (40 mL), dried over MgSO4, filtered 
and evaporated to yield crude product (0.33 g) as an orange oil. The crude product was 
purified by silica gel chromatography, eluent 10% EtOAc in hexane, to yield methyl 
(2E,4E,6E)-7-(4,4,6-trimethyl-1,3,2-dioxaborinane-2-yl)hepta-2,4,6-trienoate as a pale yellow 
solid (78 mg, 21%), mp 80.1-82.1°C. 1H NMR (400 MHz, CDCl3): δ 1.36-1.23 (9H, m), 1.56-
1.47 (1H, m), 1.80 (1H, dd, J=13.9, 3.0 Hz), 3.75 (3H, s), 4.24 (1H, ddp, J=12.3, 6.2, 3.2 Hz), 
5.71 (1H, d, J=17.4 Hz), 5.92 (1H, d, J=15.3 Hz), 6.46-6.33 (1H, m), 6.58 (1H, ddd, J=15.0, 
10.7, 0.9 Hz), 6.97 (1H, dd, J=17.4, 10.7 Hz), 7.35-7.27 (1H, m); 11B NMR (128 MHz, CDCl3): 
δ 25.90; 13C NMR (101 MHz, CDCl3): δ 23.1, 28.1, 31.2, 46.0, 51.6, 64.9, 71.0, 121.5, 131.7, 
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142.4, 144.5, 145.2, 167.4; IR (nmax, cm-1) 2972.0 (w), 2949.7 (w), 2924.1 (w) 1705.9 (s) inter 
alia; LCMS (ESI+) 264.1; HRMS (ESI+) calculated [C14H21BO4+H]+ 264.1620, found 264.1647.  
Method 2: To a dry flask was added Pd(OAc)2 (0.120 g, 0.525 mmol), P(o-tol)3 (0.315 
g, 1.50 mmol) and AgOAc (1.89 g, 11.3 mmol). The flask was purged with argon, and a solution 
of (2E,4E)-5-iodopenta-2,4-dienoate (2.50 g, 10.5 mmol) in dry, degassed MeCN (63 mL) was 
added. 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (2.2 mL, 13 mmol) was then added, the 
vessel was purged further with argon, and the reaction mixture was then heated to 50 °C with 
vigorous stirring for 19.5 hours. The mixture was allowed to cool, then diluted with Et2O (180 
mL) and passed through a short Celite/silica plug. The organic extracts were washed with 
NH4Cl (180 mL), H2O (180 mL) and brine (100 mL), dried over MgSO4, filtered, evaporated 
and dried on the high vacuum line for 2 days to give crude product as a brown oil (1.7 g, 48% 
from starting acrylate). The compound was taken on to the next stage without any further 
purification or characterisation. 
Method 3: To a dry flask was added Pd(OAc)2 (0.102 g, 0.460 mmol), P(o-tol)3 (0.276 
g, 0.911 mmol) and AgOAc (1.64 g, 9.81 mmol), followed by a solution of (2E,4E)-5-iodopenta-
2,4-dienoate (2.14 g, 8.99 mmol) in dry, degassed MeCN (54 mL). 4,4,6-Trimethyl-2-vinyl-
1,3,2-dioxaborinane (1.8 mL, 10 mmol) was then added and the reaction mixture was then 
heated to 30 °C with vigorous stirring for 18.5 hours. The mixture was allowed to cool, then 
diluted with Et2O (136 mL) and passed through a short Celite/silica plug. The solvent was 
evaporated to yield 3.8 g of a crude yellow solid containing desired product (8.67 mmol, 96% 
as determined by 1H NMR spectroscopy). This material was taken on to the next stage without 
any further purification or characterisation. 
Method 4: To a dry flask was added methyl (2E,4E)-5-iodopenta-2,4-dienoate (1.09 g, 
4.58 mmol), Pd(OAc)2 (9.5 mg, 0.043 mmol), tri(2-furyl)phosphine (0.020 g, 0.085 mmol) and 
AgOAc (0.766 g, 4.6 mmol). The flask was purged with argon, and dry, degassed MeCN (25 
mL) was added. 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.84 mL, 4.9 mmol) was then 
added, the vessel was purged further with argon, and the reaction mixture was stirred 
vigorously at room temperature for 20 hours. The mixture was diluted with Et2O (64 mL) and 
passed through a short Celite/silica plug. The solvent was evaporated to give crude product 
as a dark orange oil (1.18 g, 100%). The compound was taken on to the next stage without 
any further purification or characterisation. 
 
 
Methyl (2E,4E,6E)-7-iodohepta-2,4,6-trienoate 26 
NaOMe (21 mL, 10 mmol, 0.50 M solution in MeOH) was added dropwise to a solution 
of methyl (2E,4E,6E)-7-(4,4,6-trimethyl-1,3,2-dioxaborinane-2-yl)hepta-2,4,6-trienoate (2.28 
g, 8.6 mmol) in THF (32 mL) cooled to -78 °C under argon in the absence of light. The mixture 
was stirred at this temperature for 40 minutes and iodine monochloride (8.8 mL, 8.8 mmol, 1.0 
M solution in DCM) was added dropwise. The mixture was stirred at -78 °C for 2 hours, then 
allowed to warm to room temperature whilst stirring. The mixture was diluted with Et2O (258 
mL) and washed with Na2S2O3 (2 x 103 mL), water (103 mL) and brine (103 mL). The organic 
extracts were dried over MgSO4, filtered and evaporated to yield 4.9 g of a red solid,. 1H NMR 
(400 MHz, CDCl3): δ 3.74 (3H,s), 5.98 (1H, d, J=15.3 Hz), 6.24-6.47 (2H, m), 6.61-6.71 (1H, 
m), 7.08-7.18 (1H, m), 7.20-7.31 (1H, m). The compound was taken on to the next stage 
without any further purification or characterisation. 
 
Methyl (2E,4E,6E,8E)-9-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)nona-2,4,6,8-tetraenoate 27 
Method 1: To a dry flask was added Pd(OAc)2 (82 mg, 0.36 mmol), P(o-tol)3 (0.214 g, 
0.714 mmol) and AgOAc (1.29 g, 7.71 mmol), followed by a solution of methyl (2E, 4E, 6E)-7-
iodohepta-2,4,6-trienoate (1.70  g, 6.44 mmol) in dry, degassed MeCN (43 mL), which had 
been previously degassed by a bubbling argon needle. 4,4,6-trimethyl-2-vinyl-1,3,2-
dioxaborinane (1.5 mL, 8.6 mmol) was then added and the reaction mixture was then heated 
to 50 °C with vigorous stirring for 21 hours. The mixture was allowed to cool, then diluted with 
Et2O (150 mL) and passed through a short Celite/silica plug. The organic extracts were 
washed with H2O (150 mL) and brine (150 mL), dried over MgSO4, filtered and evaporated to 
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yield 2.2 g of crude product as a brown oil. After drying the crude product on the high vacuum 
line for 2 days, 1.2 g of an orange solid was obtained. The compound was taken on to the next 
stage without any further purification or characterisation. 
Method 2: To a dry flask was added Pd(OAc)2 (98 mg, 0.44 mmol), P(o-tol)3 (0.265 g, 
0.875 mmol) and AgOAc (1.57 g, 9.42 mmol), followed by a solution of methyl (2E, 4E, 6E)-7-
iodohepta-2,4,6-trienoate (2.28 g, 8.60 mmol) in dry, degassed MeCN (52 mL). 4,4,6-
Trimethyl-2-vinyl-1,3,2-dioxaborinane (1.4 mL, 8.6 mmol) was then added and the reaction 
mixture was then heated to 30 °C with vigorous stirring for 15.5 hours. The mixture was 
allowed to cool, then diluted with Et2O (131 mL) and passed through a short Celite/silica plug. 
The solvent was evaporated to yield 3.95 g of a crude viscous orange oil containing desired 
product (1.90 g, 76%). After drying the crude product on the high vacuum line for 2 days, 1.2 
g of an orange solid was obtained. The compound was taken on to the next stage without any 
further purification or characterisation. 
Method 3: To a dry flask was added Pd(OAc)2 (0.134 g, 0.440 mmol), P(o-tol)3 (0.364 
g, 1.20 mmol) and AgOAc (2.16 g, 13.0 mmol), followed by a solution of methyl (2E, 4E, 6E)-
7-iodohepta-2,4,6-trienoate (3.14 g, 11.9 mmol) in dry, degassed MeCN (72 mL). 4,4,6-
Trimethyl-2-vinyl-1,3,2-dioxaborinane (2.0 mL, 12 mmol) was then added and the reaction 
mixture was then heated to 30 °C with vigorous stirring for 18 hours. The mixture was allowed 
to cool, then diluted with Et2O (180 mL) and passed through a short Celite/silica plug. The 
solvent was evaporated to yield 4.5 g of a crude viscous orange oil. The crude product was 
purified by silica gel chromatography, eluent 5% EtOAc in petroleum ether, to give desired 
product as a bright yellow solid (0.90 g, 23% from iodoacrylate). 1H NMR (700 MHz, CDCl3): 
δ 1.23-1.33 (9H, m), 1.45-1.56 (1H, m), 1.79 (1H, dd, J=13.9, 2.9 Hz), 3.74 (3H, s), 4.22 (1H, 
ddt, J=11.5, 6.1, 2.9 Hz), 5.59-5.65 (1H, m), 5.84-5.93 (1H, m), 6.27-6.46 (3H, m), 6.54-6.63 
(1H, m), 6.91-7.00 (1H, m), 7.28-7.37 (1H, m); 11B NMR (128 MHz, CDCl3): δ 25.92; 13C NMR 
(176 MHz, CDCl3): δ 23.1, 28.1, 31.2, 45.9, 51.5, 64.8, 70.9, 110.1, 120.6, 130.9, 133.6, 138.9, 
140.6, 144.4, 145.8, 167.4; LCMS (ASAP) [M+H]=291.2; HRMS (ASAP) calculated 
[C16H2410BO4] 290.1804, found 290.1777. The compound was taken on to the next stage 
without any further purification or characterisation. 
Method 4: To a dry flask was added methyl (2E,4E,6E)-7-iodohepta-2,4,6-trienoate 
(0.737 g, 2.83 mmol), Pd(OAc)2 (6.4 mg, 0.028 mmol), tri(2-furyl)phosphine (0.013 g, 0.056 
mmol) and AgOAc (0.511 g, 3.07 mmol). The flask was purged with argon, and dry, degassed 
MeCN (17 mL) was added. 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.56 mL, 3.2 mmol) 
was then added, the vessel was purged further with argon, and the reaction mixture was stirred 
vigorously at room temperature for 25 hours. The mixture was diluted with Et2O (43 mL) and 
passed through a short Celite/silica plug. The solvent was evaporated to give crude product 
as a dark orange oil (1.21 g) containing desired product (2.15 mmol, 76% as determined by 
1H NMR spectroscopy. The compound was taken on to the next stage without any further 
purification or characterisation. 
 
Methyl (2E,4E,6E,8E)-9-iodonona-2,4,6,8-tetraenoate 22 
NaOMe (26 mL, 13 mmol, 0.50 M solution in MeOH) was added dropwise over 5 
minutes to a solution of a crude mixture containing methyl (2E,4E,6E,8E)-9-(4,4,6-trimethyl-
1,3,2-dioxaborinan-2-yl)nona-2,4,6,8-tetraenoate (3.20 g, 10.9 mmol) in dry THF (41 mL) 
cooled to -78 °C under argon in the absence of light. The mixture was stirred at this 
temperature for 50 minutes and iodine monochloride (2.10 g, 11.3 mmol) in dry DCM (11 mL) 
was added dropwise over 5 minutes. The mixture was stirred at -78 °C for 3 hours 40 minutes, 
then allowed to warm to room temperature. The mixture was diluted with Et2O (329 mL) and 
washed with Na2S2O3 (2 x 132 mL), H2O (132 mL) and brine (132 mL). The organic extracts 
were dried over MgSO4, filtered and evaporated to yield 3.3 g of a dark brown solid. The crude 
product was purified by silica gel chromatography at 0 oC, eluent 0-5 % EtOAc in petroleum 
ether. Pure fractions were evaporated to yield desired product as an unstable yellow solid 
(0.754 g, 20% from starting iodoacrylate) 1H NMR (700 MHz, CDCl3): δ 3.75 (3H,s), 5.92 (1H, 
d, J=15.0 Hz), 6.29 (1H, dd, J=8.7, 6.1 Hz), 6.38-6.45 (1H, m), 6.47-6.55 (2H, m), 7.07-7.14 
(1H, m), 7.27-7.34 (2H, m); 13C NMR (176 MHz, CDCl3) δ 51.7, 121.3, 131.9, 132.1, 135.7, 
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139.8, 141.1, 144.2, 145.0, 167.5; LRMS (ASAP) [M+H]= 291.0; HRMS (ASAP) [C10H12O2127I], 
calculated 290.9882, found 290.9896. 
 
Methyl (2E,4E,6E,8E,10E)-11-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)undeca-2,4,6,8,10-
pentaenoate 
To a dry flask was added Pd(OAc)2 (45 mg, 0.20 mmol), P(o-tol)3 (0.117 g, 0.394 mmol) 
and AgOAc (0.713 g, 4.26 mmol), followed by a solution of methyl (2E,4E,6E,8E)-9-iodonona-
2,4,6,8-tetraenoate (1.10 g, 3.79 mmol) in dry, degassed MeCN (24 mL). 4,4,6-Trimethyl-2-
vinyl-1,3,2-dioxaborinane (0.75 mL, 4.3 mmol) was then added and the reaction mixture was 
then heated to 50 °C with vigorous stirring for 21 hours. The mixture was allowed to cool, then 
diluted with Et2O (100 mL) and passed through a short Celite/silica plug. The organic extracts 
were washed with H2O (100 mL) and brine (100 mL), dried over MgSO4, filtered and 
evaporated to yield 1.2 g of crude product a deep red solid. A small portion (0.153 g) was 
taken and purified by silica gel chromatography, eluent 10% EtOAc in petroleum ether to verify 
presence of product. 1H NMR (400 MHz, CDCl3): δ 1.21-1.35 (9H, m), 1.41-1.51 (1H, m), 1.72-
1.88 (1H, m), 3.74 (3H, s), 4.23 (1H, ddh, J=12.2, 6.2, 2.9 Hz), 5.56-5.68 (1H, m), 5.88 (1H, 
d, J=15.3 Hz), 6.25-6.50 (5H, m), 6.92-7.02 (1H, m), 7.32 (1H, ddd, J=13.0, 11.0, 3.7 Hz); 11B 
NMR (128 MHz, CDCl3) δ 23.80. 
 
 
 
 
 
 
 
 
1-Bromo-4-[(E)-2-iodoethenyl]-2-methoxybenzene 15b 
2-[(E)-2-(4-Bromo-3-methoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(1.30 g, 3.85 mmol) was dissolved in dry THF (14 mL) and cooled to -78 °C under argon. 
NaOMe (9.2 mL, 4.6 mmol, 0.50 M in MeOH) was added dropwise and then reaction mixture 
stirred at -78 oC for 1 hour 15 minutes. Iodine monochloride (0.736 g, 3.95 mmol) in dry DCM 
(3.9 mL) was then added dropwise at this temperature and the reaction mixture stirred at -78 
°C for a further 2 hours 10 minutes. The reaction mixture was allowed to warm to room 
temperature and diluted with Et2O (116 mL), then washed with 5% Na2S2O3 (2 x 46 mL), H2O 
(46 mL) and brine (46 mL). The organics were dried over MgSO4 under argon, filtered and 
evaporated to give 1.30 g of a crude yellow solid containing desired product (0.863 g, 66%). 
1H NMR (400 MHz, CDCl3): δ 3.90 (3H, s), 6.75-6.82 (2H, m), 6.88 (1H, d, J=14.9 Hz), 7.37 
(1H, d, J=14.9 Hz), 7.48 (1H, d, J=7.9 Hz). The compound was taken on to the next stage 
without any further purification or characterisation. 
 
2-[(1E,3E)-4-(4-Bromo-3-methoxyphenyl)buta-1,3-dien-1-yl]-4,4,6-trimethyl-1,3,2-
dioxaborinane 17 
Method 1: 1-Bromo-4-[(E)-2-iodoethenyl]-2-methoxybenzene (0.863 g, 2.55 mmol) 
was dissolved in dry, degassed MeCN (15 mL) and added to a dry, argon-purged flask 
containing Pd(OAc)2 (29 mg, 0.13 mmol), P(o-tol)3 (77 mg, 0.26 mmol) and AgOAc (0.458 g, 
2.74 mmol). 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.50 mL, 2.9 mmol) was then added 
and the reaction mixture heated to 50 °C for 18 hours. The reaction mixture was allowed to 
cool to room temperature, then diluted with Et2O containing ~3 ppm BHT (38 mL) and passed 
through a short Celite/silica plug. The solvent was evaporated to give 1.37 g of crude product 
as a viscous orange oil. The crude product was purified by silica gel chromatography, elution 
gradient 0-10 % EtOAc in petroleum ether. Pure fractions were evaporated to give desired 
product as a viscous yellow oil (0.725 g, 78%). 1H NMR (600 MHz, CDCl3): δ 1.23-1.33 (9H, 
m), 1.46-1.53 (1H, m), 1.80 (1H, ddd, J=14.0, 11.2, 2.9 Hz), 3.92 (3H, s), 4.24 (1H, dddq, 
J=14.8, 9.0, 6.1, 3.1 Hz), 5.64 (1H, d, J=17.4 Hz), 6.59 (1H, d, J =15.6 Hz), 6.77-6.84 (1H, m), 
6.87-6.94 (2H, m), 7.06 (1H, dd, J=17.3, 10.5 Hz), 7.42-7.47 (1H, m); 11B NMR (128 MHz, 
	 17	
CDCl3): δ 25.56; 13C NMR (151 MHz, CDCl3): δ 23.1, 28.1, 31.2, 46.0, 64.8, 70.8, 109.7, 111.3, 
120.3, 131.7, 133.3, 133.6, 134.9, 137.9, 146.3, 155.9; LRMS (ASAP) [M+H]= 365.1; HRMS 
(ASAP) [C17H2310BO3Br] calculated 364.0960, found 364.0958. 
Method 2: 1-Bromo-4-[(E)-2-iodoethenyl]-2-methoxybenzene (1.40 g, 4.15 mmol) was 
dissolved in dry, degassed MeCN (24 mL) and added to a dry, argon-purged flask containing 
Pd(OAc)2 (46 mg, 0.21 mmol), P(o-tol)3 (0.123 g, 0.41 mmol) and AgOAc (0.733 g, 4.38 mmol). 
4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.80 mL, 4.8 mmol) was then added and the 
reaction mixture heated to 30 °C for 21.5 hours. The reaction mixture was allowed to cool to 
room temperature, then diluted with Et2O containing ~3 ppm BHT (61 mL) and passed through 
a short Celite/silica plug. The solvent was evaporated to give 1.67 g of crude product as a 
viscous orange oil. The crude product was purified by silica gel chromatography, elution 
gradient 0-10 % EtOAc in petroleum ether. Pure fractions were evaporated to give desired 
product as a viscous yellow oil (1.10 g, 73% over the two steps).  
 
1-Bromo-4-[(1E,3E)-4-iodobuta-1,3-dien-1-yl]-2-methoxybenzene 18 
2-[(1E,3E)-4-(4-bromo-3-methoxyphenyl)buta-1,3-dien-1-yl]-4,4,6-trimethyl-1,3,2-
dioxaborinane (0.725 g, 1.99 mmol) was dissolved in dry THF (7.3 mL) and cooled to -78 oC 
under argon. NaOMe (4.8 mL, 2.4 mmol, 0.50 M in MeOH) was added dropwise and then 
reaction mixture stirred at -78 °C for 55 minutes. Iodine monochloride (0.383 g, 2.05 mmol) in 
dry DCM (2.0 mL) was then added dropwise at this temperature and the reaction mixture 
stirred at -78 oC for a further 2 hours. The reaction mixture was allowed to warm to room 
temperature and diluted with Et2O (60 mL), then washed with 5% Na2S2O3 (2 x 24 mL), H2O 
(24 mL) and brine (24 mL). The organics were dried over MgSO4 under argon, filtered and 
evaporated to give a crude yellow solid containing desired product (0.708g, 98%). 1H NMR 
(400 MHz, CDCl3): δ 3.92 (3H, s), 6.47-6.49 (1H, m), 6.51-6.53 (1H, m), 6.67 (1H, ddd, J=15.6, 
10.6, 0.7 Hz), 6.85-6.91 (2H, m), 7.17 (1H, ddd, J=14.4, 10.6, 0.7 Hz), 7.44-7.48 (1H, m). The 
compound was taken on to the next stage without any further purification or characterisation. 
 
2-[(1E,3E,5E)-6-(4-Bromo-3-methoxyphenyl)hexa-1,3,5-trien-1-yl]-4,4,6-trimethyl-1,3,2-
dioxaborinane 19 
Method 1: 1-Bromo-4-[(1E,3E)-4-iodobuta-1,3-dien-1-yl]-2-methoxybenzene (0.708 g, 
1.95 mmol) was dissolved in dry, degassed MeCN (11.6 mL) and added to a dry, argon-purged 
flask containing Pd(OAc)2 (22 mg, 0.10 mmol), P(o-tol)3 (59 mg, 0.190 mmol) and AgOAc 
acetate (0.348 g, 2.08 mmol). 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.38 mL, 2.2 mmol) 
was then added and the reaction mixture heated to 50 °C for 2 days 17 hours. The reaction 
mixture was allowed to cool to room temperature then diluted with Et2O containing ~ 3 ppm 
BHT (29 mL) and passed through a short Celite/silica plug. The solvent was evaporated to 
give 1.031 g of crude product as a brown oil. The crude product was purified by silica gel 
chromatography, elution gradient 0-10% EtOAc in petroleum ether. Pure fractions were 
evaporated to yield desired product as a bright yellow oil (0.470 g, 62%). 1H NMR (600 MHz, 
CDCl3): δ 1.14-1.9 (1H, m), 1.46-1.55 (1H, m), 1.80 (1H, dd, J=13.9, 2.9 Hz), 3.92 (3H, s), 
4.24 (1H, dqd, J=12.3, 6.2, 3.0 Hz), 5.58 (1H, d, J=17.4 Hz), 6.39-6.55 (3H, m), 6.82 (1H, dd, 
J=15.5, 10.0 Hz), 6.82-6.92 (2H, m), 7.00 (1H, dd, J=17.3, 9.9 Hz), 7.45 (1H, d, J=8.1 Hz); 11B 
NMR (128 MHz, CDCl3): δ 25.49; 13C NMR (151 MHz, CDCl3): δ 23.3, 28.3, 31.4, 46.2, 56.3 
(OMe), 65.0, 71.0, 109.5, 111.0, 120.3, 130.0, 132.7, 133.5, 134.8, 136.2, 138.2, 146.5, 156.1; 
LRMS (ASAP) [M+H]= 391.1; HRMS (ASAP) [C19H2410BO3Br] calculated 389.1038, found 
389.1023.  
Method 2: 1-Bromo-4-[(1E,3E)-4-iodobuta-1,3-dien-1-yl]-2-methoxybenzene (1.0 g, 
2.8 mmol) was dissolved in dry, degassed MeCN (16 mL) and added to a dry, argon-purged 
flask containing Pd(OAc)2 (31 mg, 0.14 mmol), P(o-tol)3 (83 mg, 0.27 mmol) and AgOAc (0.491 
g, 2.93 mmol). 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.53 mL, 3.1 mmol) was then 
added and the reaction mixture heated to 30 °C for 18 hours. The reaction mixture was allowed 
to cool to room temperature then diluted with Et2O containing ~ 3 ppm BHT (41 mL) and 
passed through a short Celite/silica plug. The solvent was evaporated to give 1.10 g of crude 
product as a viscous orange oil. The crude product was purified by silica gel chromatography, 
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elution gradient 0-10% EtOAc in petroleum ether. Pure fractions were evaporated to yield 
desired product as a viscous yellow oil (0.600 g, 56%).  
 
1-Bromo-4-[(1E,3E,5E)-6-iodohexa-1,3,5-trien-1-yl]-2-methoxybenzene 20 
The crude mixture containing 2-[(1E,3E,5E)-6-(4-bromo-3-methoxyphenyl)hexa-1,3,5-
trien-1-yl]-4,4,6-trimethyl-1,3,2-dioxaborinane (0.60 g, 1.5 mmol) was dissolved in dry THF 
(5.7 mL) and cooled to -78 °C under argon. NaOMe (3.7 mL, 1.9 mmol, 0.50M in MeOH) was 
added dropwise and then reaction mixture stirred at -78 °C for 40 minutes. Iodine monochloride 
(0.296 g, 1.59 mmol) in dry DCM (1.2 mL) was then added dropwise at this temperature and 
the reaction mixture stirred at -78 °C for a further 2 hours. The reaction mixture was allowed 
to warm to room temperature and diluted with Et2O (47 mL), then washed with 5% Na2S2O3 
(2 x 19 mL), H2O (19 mL) and brine (19 mL). The organics were dried over MgSO4 under 
argon, filtered and evaporated to give a bright yellow solid containing the desired product (1.26 
mmol, 84%) as determined by 1H NMR spectroscopy, which was found to rapidly decompose. 
1H NMR (400 MHz, CDCl3): δ 3.93 (3H, s), 6.34 (1H, dd, J=7.4, 1.2 MHz), 6.56-6.63 (2H, m), 
6.81 (1H, dd, J=9.9, 7.6 Hz), 6.86-6.94 (3H, m), 7.11 (1H, dd, J=14.3, 10.6 Hz), 7.45-7.49 (1H, 
m). The compound was taken on to the next stage without any further purification or 
characterisation 
 
2-[(1E,3E,5E,7E)-8-(4-Bromo-3-methoxyphenyl)octa-1,3,5,7-tetraen-1-yl]-4,4,6-trimethyl-
1,3,2-dioxaborinane 21 
Method 1: 1-Bromo-4-[(1E,3E,5E)-6-iodohexa-1,3,5-trien-1-yl]-2-methoxybenzene 
(0.233 g, 0.60 mmol) was dissolved in dry, degassed MeCN (3.7 mL) and added to a dry, 
argon-purged flask containing Pd(OAc)2 (7.0 mg, 0.031 mmol), P(o-tol)3 (18 mg, 0.060 mmol) 
and AgOAc (0.109 g, 0.645 mmol). 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.12 mL, 0.69 
mmol) was then added and the reaction mixture heated to 50 °C for 20 hours. The reaction 
mixture was allowed to cool to room temperature, then diluted with Et2O containing ~3 ppm 
BHT (25 mL) and passed through a short Celite/silica plug. The solvent was evaporated to 
give 0.296 g of crude product as a dark red viscous oil. The crude product was purified by 
silica gel chromatography, elution gradient 0-10% EtOAc in petroleum ether. Pure fractions 
were evaporated to give desired product as a bright orange gum (0.146 g, 58%).  
Method 2: 1-Bromo-4-[(1E,3E,5E)-6-iodohexa-1,3,5-trien-1-yl]-2-methoxybenzene 
(0.506 g, 1.30 mmol) was dissolved in dry, degassed MeCN (7.8 mL) and added to a dry, 
argon-purged flask containing Pd(OAc)2 (15 mg, 0.067 mmol), P(o-tol)3 (39 mg, 0.13 mmol) 
and AgOAc (0.232 g, 1.39 mmol). 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane (0.25 mL, 1.5 
mmol) was then added and the reaction mixture heated to 30 oC for 18.5 hours. The reaction 
mixture was allowed to cool to room temperature, then diluted with Et2O containing ~3 ppm 
BHT (19 mL) and passed through a short Celite/silica plug. The solvent was evaporated to 
give 0.704 g of crude product as a dark red viscous oil. The crude product was purified by 
silica gel chromatography, elution gradient 0-10% EtOAc in petroleum ether. Pure fractions 
were evaporated to give desired product as a bright orange gum (0.289 g, 53%). 1H NMR (600 
MHz, CDCl3): δ 1.24-1.6 (9H, m), 1.46-1.54 (1H, m), 1.79 (1H, dd, J=13.8, 3.0 Hz), 3.92 (3H, 
s), 4.24 (1H, ddqd, J=12.3, 9.1, 6.0, 2.9 Hz), 5.55 (1H, d, J=17.3 Hz), 6.03-6.18 (1H, m), 6.39-
6.44 (3H, m), 6.48-6.52 (1H, m), 6.84-6.94 (3H, m), 6.95-7.04 (1H, m), 7.45 (1H, d, J=8.1 Hz); 
11B NMR (128 MHz, CDCl3): δ 25.37; 13C NMR (151 MHz, CDCl3): δ 23.3, 28.3, 31.4, 46.2, 
56.3, 64.9, 71.0, 109.6, 110.9, 120.2, 129.7, 130.0, 132.0, 133.5, 134.1, 134.2, 135.1, 135.8, 
138.3, 146.7, 156.1; IR (nmax, cm-1) 1568.7 (m), 1587.0 (m), 1607.7 (m), 2911.1 (m), 2938.7 
(m), 2971.6 (m) inter alia; LRMS (ASAP) [M+H]= 417.1; HRMS (ESI) [C21H2610BO3Br] 
calculated 415.1195, found 415.1213.  
 
 
Methyl (2E,4E,6E,8E,10E)-11-(4-bromo-3-methoxyphenyl)undeca-2,4,6,8,10-pentaenoate 4 
Method 1: 2-[(E)-2-(4-Bromo-3-methoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (26 mg, 0.076 mmol), methyl (2E, 4E, 6E,8E)-9-iodonona-2,4,6,8-tetraenoate 
(18 mg, 0.061 mmol), Pd(PPh3)4 (7.0 mg, 0.0061 mmol) and Ag2O (17 mg, 0.076 mmol) were 
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added to a dry flask and the flask purged with argon. Dry, degassed DME (0.46 mL) was then 
added and the reaction stirred at 40 °C for 17 hours. The reaction mixture was then diluted 
with EtOAc containing ~ 3ppm BHT (6.0 mL) and passed through a short plug of Celite/silica. 
The solvent was evaporated to give 55 mg of a green residue. The crude product was purified 
by silica gel chromatography at 0 °C, eluent benzene, to give desired product as a bright yellow 
solid (10 mg, 34%), mp 207.3-208.9 °C. 1H NMR (700 MHz, CDCl3): δ 3.75 (3H, s, 3.92 (3H, 
s), 5.89 (1H, d, J=15.2 Hz), 6.37 (2H, ddd, J=15.1, 11.2, 4.3 Hz), 6.41-6.52 (3H, m), 6.55 (1H, 
d, J=15.5 Hz), 6.62 (1H, dd, J=14.7, 11.2 Hz), 6.80-6.85 (1H, m), 6.87-6.93 (2H, m), 7.29-7.35 
(1H, m), 7.47 (1H, d, J=8.1 Hz); 13C NMR (176 MHz, CDCl3): δ 51.7, 56.3, 109.6, 111.3, 120.3, 
120.5, 129.7, 130.5, 132.6, 133.1, 133.5, 133.7, 135.4, 137.2, 138.0, 140.8, 144.7, 156.2, 
167.7; IR (nmax, cm-1)  inter alia 1703.9 (m),  2912.8 (w), 2924.4 (w), 2938.4 (w),  2952.3 (w); 
LRMS (ASAP) M= 374.1; HRMS (ASAP) [C19H19O3Br] calculated 374.0499, found 374.050. 
UV (CHCl3 5µM, nm) 397 (ε 67 000), 417 (ε 56 000). Fluorescence (CHCl3 100 nM, nm) 498, 
527, 566, 594. 
Method 2:  2-[(E)-2-(4-Bromo-3-methoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (26 mg, 0.076 mmol), methyl (2E, 4E, 6E,8E)-9-iodonona-2,4,6,8-tetraenoate 
(18 mg, 0.061 mmol), Pd(OAc)2 (1.0 mg, 0.0061 mmol), PPh3 (5.0 mg, 0.018 mmol) and 
Ag2CO3 (34 mg, 0.12 mmol) were added to a dry flask and the flask purged with argon. Dry, 
degassed MeCN (0.46 mL) was then added and the reaction stirred at room temperature for 
17 hours. The reaction mixture was then diluted with EtOAc containing ~ 3ppm BHT (6.0 mL) 
and passed through a short plug of Celite/silica. The solvent was evaporated to give 82 mg of 
a green residue. The crude product was purified by silica gel chromatography at 0 oC, eluent 
benzene, to give desired product as a bright yellow solid (19 mg, 81%).  
 
Methyl (2E,4E,6E,8E,10E,12E,14E,16E)-17-(4-bromo-3-methoxyphenyl)heptadeca-
2,4,6,8,10,12,14,16-octaenoate 9b 
2-[(1E,3E,5E,7E)-8-(4-Bromo-3-methoxyphenyl)octa-1,3,5,7-tetraen-1-yl]-4,4,6-
trimethyl-1,3,2-dioxaborinane (27 mg, 0.065 mmol), methyl (2E,4E,6E,8E)-9-iodonona-
2,4,6,8-tetraenoate (16 mg, 0.055 mmol), Pd(PPh3)4 (7.0 mg, 0.025 mmol) and Ag2O (15 mg, 
0.065 mmol) were added to a dry flask and purged with argon. Dry, degassed DME (0.50 mL) 
was added and the reaction heated to 40 °C for 26 hours. The reaction mixture was allowed 
to cool to room temperature and then diluted with Et2O containing ~ 3 ppm BHT (10 mL) and 
passed through a Celite plug. The organics were evaporated to give 25 mg of an orange 
residue. The crude product was dissolved in CDCl3, and then cooled to 0 °C. Petroleum ether 
was added until precipitation of a red solid was achieved. The solid was collected on a sinter 
funnel and washed with cold petroleum ether, then the solid collected by dissolving in CHCl3 
and then removing the solvent in vacuo to give 7 mg of a red solid containing desired product 
(0.5 mg, 2 %) by 1H NMR spectroscopy.  1H NMR (700 MHz, CDCl3): δ 3.74 (3H, s), 3.95 (3H, 
s), 5.91-5.99 (3H, m), 6.24-6.47 (12H, m), 6.85-6.92 (2H, m), 7.43-7.50 (2H, m); LRMS (ASAP) 
M+H= 453.1; HRMS (ASAP) [C25H26O3Br] calculated 453.1065, found 453.1058. 
 
Conditions used for HM ligand screen 
Methyl (2E)-3-iodoprop-2-enoate (0.141 g, 0.665 mmol), Pd(OAc)2 (15 mg,  
0.067 mmol), ligand  (0.13 mmol) and AgOAc (0.120 g, 0.721 mmol) were added to dry flasks 
under argon in the absence of light. Degassed MeCN (4.0 mL) was added to each flask, 
followed by 4,4,6-trimethyl-2-vinyl-1,3,2-dioxaborinane (0.13 mL, 0.76 mmol) under a positive 
pressure of argon. The flasks were then purged with argon for 2 minutes, and then stirred 
vigorously at room temperature, with conversion monitored at 1.5 hours, 3 hours and 24 hours 
by 1H NMR. The HM:SM ratio was also determined by 1H NMR spectroscopy. 
 
Conditions used for catalyst loading screen 
Methyl (2E)-3-iodoprop-2-enoate (0.141 g, 0.665 mmol), Pd(OAc)2, tri(2-
furyl)phosphine (2 equivalents relative to catalyst) and AgOAc (0.120 g, 0.721 mmol) were 
added to dry round-bottomed flasks under argon in the absence of light. Degassed MeCN (4.0 
mL) was added to each flask, followed by 4,4,6-trimethyl-2-vinyl-1,3,2-dioxaborinane (0.13 
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mL, 0.76 mmol) under a positive pressure of argon. The flasks were then purged with argon 
for 2 minutes, then stirred vigorously at room temperature, with conversion monitored at 3 
hours and 24 hours by 1H NMR spectroscopy. The HM:SM ratio was also determined by 1H 
NMR spectroscopy. 
 
Acknowledgements 
We would like to thank the EPSRC for the award of a Doctoral Training Grant to K. S. M. 
 
References 
1) K. S. Madden, F. A. Mosa and A. Whiting, Org. Biomol. Chem., 2014, 12, 7877-7899. 
2) C. Thirsk and A. Whiting, J. Chem. Soc., Perkin Trans. 1, 2002, 999-1023.  
3) a) G. Mehta and H. S. Prakash Rao, "Synthesis of Conjugated Dienes and Polyenes," 
Patai’s Chemistry of Functional Groups, Z. Rappoport Ed., Wiley, Chichester, 1997; b) M. De 
Paolis , I. Chataigner and J. Maddaluno, Top. Curr. Chem. 2012, 327, 87–146.  
4) a) A. R. Hunt, S. K. Stewart and A. Whiting, Tetrahedron Lett., 1993, 34, 3599-3602; b) S. 
K. Stewart and A. Whiting, Tetrahedron Lett., 1995, 36, 3925-3928; c) S. K. Stewart and A. 
Whiting, Tetrahedron Lett., 1995, 36, 3929-3932; d) A. P. Lightfoot, S. J. R. Twiddle and A. 
Whiting, Synlett, 2005, 529-531; e) A. P. Lightfoot, S. J. R. Twiddle and A. Whiting, Org. 
Biomol. Chem., 2005, 3, 3167-3172; f) K. S. Madden, S. David, J. P. Knowles and A. 
Whiting, Chem. Comm., 2015, 51, 11409-11412. 
5) a) N. Hénaff and A. Whiting, Org. Lett., 1999, 1, 1137; b) N. Hénaff and A. Whiting, 
Tetrahedron, 2000, 56, 5193; c) a) A. S. Batsanov, J. P. Knowles and A. Whiting, J. Org. 
Chem., 2007, 72, 2525-2532; d) J. P. Knowles, V. O’Connor and A. Whiting, Org. Biomol. 
Chem., 2011, 9, 1876-1886. 
6) J. Li, A. S. Grillo and M. D. Burke, Acc. Chem. Res. 2015, 48, 2297-2307. 
7) S. A. Davis, L. A. Della Ripa, L. Hu, A. G. Cioffi, T. V. Pogorelov, C. M. Rienstra, M. D. 
Burke, J. Am. Chem. Soc., 2015, 137, 15102-15104. 
8) a) M. P. Starr, C. L. Jenkins, L. B. Bussey and A. G. Andrewes, Arch. Microbiol., 1977, 
113, 1–9; A. G. Andrewes, S. Hertzberg, S. Liaaen-Jensen and M. P. Starr, Acta Chem. 
Scand., 1973, 27, 2383–95; c) A. G. Andrewes, C. L. Jenkins, M. P. Starr, J. Shepherd and 
H. Hope, Tetrahedron Lett., 1976, 17, 4023–4024. 
9) a) K. S. Madden, B. Laroche, S. David, A. S. Batsanov, D. Thompson, J. P. Knowles and 
A. Whiting, Eur. J. Org. Chem., 2018, 38, 5312-5322; b) K. S. Madden, H. R. E. Jokhoo, F. D. 
Conradi, J. P. Knowles, C. W. Mullineaux and A. Whiting, Org. Biomol. Chem., 2019, 17, 3752-
3759. 
10) S. Garrais, J. Turkington and W. P. D. Goldring, Tetrahedron, 2009, 65, 8418 – 8427. 
11) This was clear from the appearance of cis J-couplings in the crude 1H NMR spectrum and 
associated broadening of the aliphatic region. 
12) See for example, E. P. Gillis and M. D. Burke, Aldrichimica Acta., 2009, 42, 17–27. 
13) A. P. Lightfoot, G. Maw, C. Thirsk, S. Twiddle, A. Whiting, A. Tetrahedron Lett. 2003, 44, 
7645-7648. 
14) G. Maw, C. Thirsk and A. Whiting, Tetrahedron Lett. 2001, 42, 8387-8390. 
15) P. W. N. M. van Leeuwen, P. C. J. Kamer, J. N. H. Reek and P Dierkes, Chem. Rev. 2000, 
100, 2741. 
16) C. A. Tolman, Chem. Rev., 1977, 77, 313. 
17) The cone angle for the tris(2-methoxyphenyl)phosphine has not been reported, nor has a 
direct comparison of electronic parameters. However, one would expect a slight increase in 
cone angle and electron density. 
18) V. P. W. Böhm and W. A. Herrmann, Chem. Eur. J., 2001, 7, 4191. 
19) W. A. Herrmann, C. Brossmer, C.-P. Reisinger, T. H. Riermeier, K. Ofele, and M. Beller, 
Chem. Eur. J., 1997, 3, 1357. 
20) See for instance N. G. Andersen and B. A. Keay, Chem. Rev., 2001, 101, 997-1030. 
21) a) Y. Shen and P. Ronald, Microbes Infect., 2002, 4, 1361–1367; b) A. R. Poplawsky, S. 
C. Urban and W. Chun, Appl. Environ. Microbiol., 2000, 66, 5123–5127; c) A. R. Poplawsky, 
M. D.  Kawalek and N. W. Schaad, Mol. Plant-Microbe Interact., 1993, 6, 545–545; d) Chun, 
	 21	
J. Cui, and A. R. Poplawsky, Physiol. Mol. Plant Pathol., 1997, 51, 1–14; e) A. R. Poplawsky 
and W. Chun, J. Bacteriol., 1997, 179, 439–444; f) A. R. Poplawsky and Chun, Mol. Plant-
Microbe Interact., 1998, 11, 466–475; g) A. R. Poplawsky, W. Chun, H. Slater, M. J. Daniels 
and J. M. Dow, Mol. Plant-Microbe Interact.,1998, 11, 68–70; h) A. R. Poplawsky, D. M. 
Walters, P. E. Rouviere and W. Chun, Mol. Plant Pathol., 2005, 6, 653–657; i) A. Y; j) L. 
Zhou, J. Y. Wang, J. Wu, J. Wang, A. R. Poplawsky, S. Lin, B. Zhu, C. Chang, T. Zhou, L. H. 
Zhang, and Y. W. He, Mol. Microbiol., 2013, 87, 80–93; k) L. Zhou, T. W. Huang, J. Y. 
Wang, S. Sun, G. Chen, A. R. Poplawsky and Y. W. He, Mol. Plant. Microbe. Interact., 2013, 
26, 1239–48; l) L. Rajagopal, C. S. S. Sundari, D. Balasubramanian and R. V. Sonti, FEBS 
Lett., 1997, 415, 125–128. 
 
 
